PATENT CLAIM ANALYSIS

Application Number: 15762165
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "312000"]

Abstract:
An ophthalmic composition is provided that includes rebamipide and a method for preparing the same. The ophthalmic composition of maintains its transparency for a long time even in a physiologically neutral to weakly basic pH range that does not injure the cornea and conjunctiva of a patient suffering from dry eye and has improved stability so as not to be re-dispersed.

Claim (Index 1):
An ophthalmic composition comprising:\n (1) rebamipide; (2) an anti-recrystallizing agent selected from the group consisting of a cyclodextrin derivative, an amino acid, and mixtures thereof; and (3) a buffering agent.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 90.0
- Lexical Diversity: 1.28571
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['12447065', '15200960', '14923845', '15667033', '11667313']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6895034457107196
- 35 USC 102 Novelty (BERT): 0.4855109526457254
- Combined Prediction Score: 0.6691041964042203
- Mean Citation Score: 150.267014
- Max Citation Score: 163.80756
- Similarity Product: 116.1336906554818

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test